Assistant Professor, Medicine, Medical College of Wisconsin

Oncology

Dr. Nicholas Choong, MD

Nicholas Choong works in the field of Oncology. Nicholas Choong, MD is a published MD. He has 28 publications published. The most current publication "Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors."

Publications

Population pharmacokinetics and dosing implications for cobimetinib in patients with solid Tumors.
Morbidities of lung Cancer surgery in obese patients.
Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell Carcinoma of the head-and-neck.
Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia.
Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia.
Phase II study of sunitinib malate in head and neck squamous cell Carcinoma.
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced Carcinoma of the esophagus or gastroesophageal junction.
EphA2 mutation in lung squamous cell Carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
Complete and durable response of choroid metastasis from non-small cell lung Cancer with systemic bevacizumab and chemotherapy.
Recurrent laryngeal nerve palsy on integrated positron emission tomography-computed tomography.
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung Cancer.
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung Cancer.
Key signaling pathways and targets in lung Cancer therapy.
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung Cancer.
Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung Cancer.
Epidermal growth factor receptor directed therapy in head and neck Cancer.
Therapeutic targeting of receptor tyrosine kinases in lung Cancer.
Small cell carcinoma of the urinary Bladder. The Mayo Clinic experience.
Bilateral carotid body paraganglioma.
Intramural gastric abscess: case history and review.
28-year-old man with recurrent fever.
67-year-old man with hepatitis C infection and abdominal distention.
Forthcoming receptor tyrosine kinase inhibitors.
Influence of adiposity in the blunted whole-body protein anabolic response to insulin with aging.
Gefitinib response of erlotinib-refractory lung Cancer involving meninges--role of EGFR mutation.
TracheoEsophageal fistula associated with bevacizumab 21 months after completion of radiation therapy.
Expanding role of the medical oncologist in the management of head and neck Cancer.

Conditions Treated

Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
Bladder Cancer
View All

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Education

University of Chicago
Mayo School of Graduate Medical Education
McGill University Faculty of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Matthew R. Zibelman, MD This Doctor is OpenDoctor Recommended.
	Dr. Leena Maramattom, MD This Doctor is OpenDoctor Recommended.
	Dr. David Friedland, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. John P. Hanson Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Husam S. Tarawneh, MD This Doctor is OpenDoctor Recommended.
	Dr. Faisal Saghir, MD This Doctor is OpenDoctor Recommended.